International trade · 05/12/1994Updated: 10/18/2026 · 1 min read
Patent Office Grants Interim Extension for Motilium Drug Product
Summary
The U.S. Patent and Trademark Office has issued a certificate under the Patent Term Extension Act for a one-year extension of the patent term for Motilium, a human drug product
Original source language: Federal Register — Department of CommerceOpen original release →